Tudor Investment Corp
NAVB

Tudor Investment Corp’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Tudor Investment Corp’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,327
Closed -$6K – 1468
2019
Q1 		$6K Hold
2,327
– – ﹤0.01% 1074
2018
Q4 		$5K Hold
2,327
– – ﹤0.01% 981
2018
Q3 		$11K Hold
2,327
– – ﹤0.01% 1059
2018
Q2 		$11K Hold
2,327
– – ﹤0.01% 1014
2018
Q1 		$17K Hold
2,327
– – ﹤0.01% 965
2017
Q4 		$17K Hold
2,327
– – ﹤0.01% 1062
2017
Q3 		$19K Hold
2,327
– – ﹤0.01% 1057
2017
Q2 		$24K Hold
2,327
– – ﹤0.01% 995
2017
Q1 		$27K Hold
2,327
– – ﹤0.01% 1343
2016
Q4 		$30K Hold
2,327
– – ﹤0.01% 1347
2016
Q3 		$43K Hold
2,327
– – ﹤0.01% 1377
2016
Q2 		$25K Hold
2,327
– – ﹤0.01% 1565
2016
Q1 		$44K Hold
2,327
– – ﹤0.01% 1660
2015
Q4 		$62K Buy
2,327
+495
+27% +$17.2K ﹤0.01% 1567
2015
Q3 		$84K Buy
1,832
+1,316
+255% +$49.6K ﹤0.01% 1446
2015
Q2 		$17K Hold
516
– – ﹤0.01% 1457
2015
Q1 		$16K Hold
516
– – ﹤0.01% 1419
2014
Q4 		$19K Buy
+516
New +$14.2K ﹤0.01% 1414
2014
Q3 		– Sell
-1,145
Closed -$34K – 1552
2014
Q2 		$34K Hold
1,145
– – ﹤0.01% 1132
2014
Q1 		$42K Sell
1,145
-470
-29% -$17.8K ﹤0.01% 1158
2013
Q4 		$67K Buy
+1,615
New +$63.2K ﹤0.01% 1223

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tudor Investment Corp's NAVB Position: Q2 2019 in Review

Tudor Investment Corp sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2019, closing a stake of 2,327 shares — an estimated $6K sold.

Tudor Investment Corp first reported a position in NAVB in Q4 2013 and held it in 21 quarters. The position peaked at $84K in Q3 2015. 27 funds tracked by Wall St. Rank hold NAVB as of Q2 2019.

  • Tudor Investment Corp reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Tudor Investment Corp sold 2,327 Navidea Biopharmaceuticals Inc. shares in Q2 2019, an estimated $6K.
  • Tudor Investment Corp first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2013 and held it in 21 quarters.
  • Tudor Investment Corp's Navidea Biopharmaceuticals Inc. position peaked at $84K in Q3 2015.
  • 27 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2019.

Based on Tudor Investment Corp's 13F filing for Q2 2019, filed 14 Aug 2019.